Related Experiment Video
Updated: Jun 13, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and
Davin M Henderson1, Ann Lee, James M Ervasti
1Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
Mutations in the dystrophin gene cause Duchenne muscular dystrophy (DMD) most commonly through loss of protein expression. In a small subpopulation of patients, missense mutations can cause DMD, Becker muscular dystrophy, or X-linked cardiomyopathy. Nearly one-half of disease-causing missense mutations are located in actin-binding domain 1 (ABD1) of dystrophin. To test the hypothesis that ABD1 missense mutations cause disease by impairing actin-binding activity, we engineered the K18N, L54R, D165V, A168D, L172H, and Y231N mutations into the full-length dystrophin cDNA and characterized the biochemical properties of each mutant protein. The K18N and L54R mutations are associated with the most severe diseases in humans and each caused a small but significant 4-fold decrease in actin-binding affinity, while the affinities of the other four mutant proteins were not significantly different from WT dystrophin. More interestingly, WT dystrophin was observed to unfold in a single-step, highly cooperative manner. In contrast, all six mutant proteins were significantly more prone to thermal denaturation and aggregation. Our results suggest that missense mutations in ABD1 may all cause loss of dystrophin function via protein instability and aggregation rather than through loss of ligand binding function. However, more severe disease progressions may be due to the combinatorial effects of some mutations on both protein aggregation and impaired actin-binding activity.
Insights
Duchenne muscular dystrophy (DMD) missense mutations in dystrophin
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Duchenne muscular dystrophy (DMD) is often caused by dystrophin loss.
- Missense mutations in dystrophin's actin-binding domain 1 (ABD1) are linked to DMD, Becker muscular dystrophy, and X-linked cardiomyopathy.
- Understanding the molecular mechanisms of ABD1 mutations is crucial for disease insight.
Purpose of the Study:
- To investigate whether missense mutations in dystrophin's ABD1 impair actin-binding activity.
- To characterize the biochemical properties of six engineered ABD1 missense mutations.
- To determine the primary cause of disease associated with ABD1 missense mutations.
Main Methods:
- Engineered six specific missense mutations (K18N, L54R, D165V, A168D, L172H, Y231N) into full-length dystrophin cDNA.
- Characterized biochemical properties of wild-type (WT) and mutant dystrophin proteins.
- Assessed actin-binding affinity and thermal denaturation/aggregation propensity.
Main Results:
- Two severe mutations (K18N, L54R) showed a minor decrease in actin-binding affinity.
- All six mutant dystrophin proteins exhibited increased susceptibility to thermal denaturation and aggregation compared to WT.
- WT dystrophin unfolded cooperatively, while mutants showed less stable unfolding.
Conclusions:
- Dystrophin ABD1 missense mutations likely cause disease primarily through protein instability and aggregation.
- Impaired actin-binding may contribute to disease severity in some cases, potentially in combination with aggregation.
- These findings offer new perspectives on the molecular pathology of dystrophinopathies.
Related Concept Videos
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Satellite Stem Cells and Muscular Dystrophy
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
The Sarcomere
Each myosin...
Introduction to Actin

